A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ophthalmological Center After S.V. Malayan
Yerevan, Armenia
Lilit Voskanyan, MD, PhDRecruiting
- Centre Monticelli Paradis D'Ophtalmologie
Marseille, France
François Devin, MDRecruiting
- Akhali Mzera Limited
Tbilisi, Georgia
Shalva Skhirtladze, MDRecruiting - Caucasus Medical Centre Llc
Tbilisi, Georgia
Mikheil Omiadze, MD, PhDRecruiting - Chichua Medical Centre Mzera Llc
Tbilisi, Georgia
George Chichua, MD, PhDRecruiting
- Universitäts-Augenklinik Bonn
Bonn, Germany
Kristina Pfau, MDRecruiting
- Institute of Eye Surgery (ioes Waterford)
Waterford, Ireland
Eugene Ng, MDRecruiting
- Hadassah Medical Center
Jerusalem, Israel
Tareq Jaouni, MDRecruiting - Tel Aviv Medical Center
Tel Aviv, Israel
Omer Trivizki, MDRecruiting
- Medical Retina & Imaging Unit, Irccs Multimedica, Ospedale San Giuseppe
Milan, Milano, Italy
Stela Vujosevic, MDRecruiting - Unità Di Oculistica, Irccs Ospedale San Raffaele
Milan, Milano, Italy
Francesco Bandello, MDRecruiting
- Retina-Vitreous Associates Medical Group
Beverly Hills, California, United States
David Boyer, MDRecruiting - Bay Area Retina Associates
Walnut Creek, California, United States
Roger Goldberg, MDRecruiting - Cumberland Valley Retina Consultants
Hagerstown, Maryland, United States
David Warrow, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Jan 2025
- Primary completion
- 30 Mar 2027
- Completion
- 30 May 2027
- Last update posted
- 6 Feb 2026
- Registered enrollment
- 110
- Registry id
- NCT06659549
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.